Alexandria Real Estate Equities
ARE
#2394
Rank
A$11.32 B
Marketcap
A$65.05
Share price
-2.57%
Change (1 day)
-21.65%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

EPS for Alexandria Real Estate Equities (ARE)

EPS in 2023 (TTM): A$2.08

According to Alexandria Real Estate Equities 's latest financial reports the company's current EPS (TTM) is A-$12.25. In 2022 the company made an earnings per share (EPS) of A$4.56 a decrease over its 2021 EPS that were of A$5.52.

EPS history for Alexandria Real Estate Equities from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A$2.08-54.34%
2022A$4.56-17.41%
2021A$5.52-35.32%
2020A$8.5389.03%
2019A$4.51-12.68%
2018A$5.17124.68%
2017A$2.30-179%
2016A-$2.91-221.95%
2015A$2.3962.38%
2014A$1.47-36.87%
2013A$2.3346.79%
2012A$1.59-36.63%
2011A$2.50-20.74%
2010A$3.16-21.66%
2009A$4.03-3.48%
2008A$4.188.3%
2007A$3.8616.23%
2006A$3.320.88%
2005A$3.29-9.27%
2004A$3.62-23.36%
2003A$4.7381.56%
2002A$2.607.19%
2001A$2.43-7.22%
2000A$2.6221.62%
1999A$2.15-8.07%
1998A$2.34-217.81%
1997A-$1.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
A$1.03-108.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$44.96-466.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$25.29-306.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A-$4.51-63.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$8.57-169.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$6.58-153.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$28.83-335.27%๐Ÿ‡บ๐Ÿ‡ธ USA